Financials
Financial year 2025
Gross margin
€ 406,506
▲ 1% vs 2024
Profit
Growing€ 22,729
▲ 1% vs 2024
Debts
Low€ 167,274
▲ 52% vs 2024
MERIDIAN BIOSCIENCE EUROPE from Braine-l'Alleud, company number BE0408081968, closed financial year 2025 with a result of € 22,729 after tax. For that financial year MERIDIAN BIOSCIENCE EUROPE recorded a gross margin of € 406,506 and equity of € 450,490. Compared with financial year 2024, the result moved from € 22,536 to € 22,729. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.
What happened at MERIDIAN BIOSCIENCE EUROPE?
What happened at MERIDIAN BIOSCIENCE EUROPE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 22,729 (▲ 1% vs 2024). Source: NBB ↗
- Emerson Christopher MOSER stepped down as director. NBB
- Andrew Scott KITZMILLER stepped down as director. NBB
- Tony SERAFINI-LAMANNA stepped down as director. NBB
- Emerson Christopher MOSER became a director. NBB
- Andrew Scott KITZMILLER became a director. NBB
- Tony SERAFINI-LAMANNA became a director. NBB
- New establishment in Braine-l'Alleud. KBO
In short
From € 487,186 profit in 2022 to € 22,729 profit in 2025.
Paid € 112,223 in corporate taxes since 2022.
Best year ever: 2022, with € 487,186 profit.
On average € 497,200 of value added per employee in 2023.
A new publication or filing at MERIDIAN BIOSCIENCE EUROPE? We notify you, reason included.
Follow MERIDIAN BIOSCIENCE EUROPENeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Emerson Christopher MOSER
Director
since 2025 · until 2026
Andrew Scott KITZMILLER
Director
since 2025 · until 2026
Tony SERAFINI-LAMANNA
Managing director
since 2025 · until 2026
Establishments
Establishment units
Physical locations of this company
Boulevard de France 9
1420 Braine-l'Alleud
Avenue du Japon 2
1420 Braine-l'Alleud
Active since 1 July 1979
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 53 companies are registered at this address.
ODYSSEY FINANCIAL TECHNOLOGIES
€ 963,129 gross margin · 2025
SET SEVEN
€ -41,144 gross margin · 2025
TAXI BERNARD DUBOIS
€ 3,463 gross margin · 2025
Elite Limousine Service
€ 88,566 gross margin · 2024
DIESELMOT
€ 5,387 gross margin · 2025
+48 more
Website
Technologies
Hosting & Email
Email provider
Mimecast
Hosting
GOOGLE-CLOUD-PLATFORM - Google LLC, US
Domain
Domain
meridianbioscience.eu
Registrar
Network Solutions Europe, LLC
Website info
Features
Security
Details
- Company number
- 0408.081.968
- VAT number
- BE 0408.081.968
- Registered office
- Boulevard de France 9, 1420 Braine-l'Alleud
- Names & denominations
- MERIDIAN BIOSCIENCE EUROPE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 8 February 1971
- Peppol
- Active · Active since 1 Jan 2001
- Contact
- meridianbioscience.eu
- Activities · NACE
Vervaardiging van farmaceutische grondstoffen
Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden
Vervaardiging van niet-elektrische apparaten en instrumenten voor de geneeskunde, de tandheelkunde en de veeartsenijkunde